Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rosta

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Magyar Onkologia|June 7, 2002
[Clinical features and guidelines of treatment of mucosa-associated lymphoid tissue lymphoma of stomach]T Schneider, Zs Molnár, E Várady, et al.
Orvosi Hetilap|February 19, 1998
[Comments on cancer analgesia and clinical morphine intolerance]I Bodrogi, D Embey-Isztin, M Kásler, et al.
Radiologia Diagnostica|January 1, 1988
Comparison of 99mTc lymphoscintigraphy, ultrasonography and lymphangiography in patients with malignant lymphomaL Jánoskuti, A Rosta, I Szilvási, et al.
Pathology Oncology Research : POR|April 24, 2008
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centresA Illés, Zs Simon, E Tóth, et al.
Orvosi Hetilap|July 20, 1997
[Determination of dihydropyrimidine dehydrogenase in the prediction of toxic side effects of 5-fluorouracil]C Katona, A Rosta, K Tóth, et al.
Oncology|September 10, 1998
Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patientsC Katona, J Kralovánszky, A Rosta, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Role of endothelin-1 in the development of a special type of cardiomyopathyA Zsáry, S Szücs, T Schneider, et al.
Leukemia & Lymphoma|March 26, 2002
Second malignancies after treatment for Hodgkin's diseaseE Várady, B Deák, Z S Molnár, et al.
Orvosi Hetilap|June 29, 1997
[Merkel cell tumor]G Fónyad, A Rosta, E K Tóth, et al.
Neoplasma|May 1, 2010
Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long term follow-up resultsZ Molnar, Z Simon, Z Borbenyi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Magyar Onkologia|June 7, 2002
[Clinical features and guidelines of treatment of mucosa-associated lymphoid tissue lymphoma of stomach]T Schneider, Zs Molnár, E Várady, et al.
Orvosi Hetilap|February 19, 1998
[Comments on cancer analgesia and clinical morphine intolerance]I Bodrogi, D Embey-Isztin, M Kásler, et al.
Radiologia Diagnostica|January 1, 1988
Comparison of 99mTc lymphoscintigraphy, ultrasonography and lymphangiography in patients with malignant lymphomaL Jánoskuti, A Rosta, I Szilvási, et al.
Pathology Oncology Research : POR|April 24, 2008
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centresA Illés, Zs Simon, E Tóth, et al.
Orvosi Hetilap|July 20, 1997
[Determination of dihydropyrimidine dehydrogenase in the prediction of toxic side effects of 5-fluorouracil]C Katona, A Rosta, K Tóth, et al.
Oncology|September 10, 1998
Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patientsC Katona, J Kralovánszky, A Rosta, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Role of endothelin-1 in the development of a special type of cardiomyopathyA Zsáry, S Szücs, T Schneider, et al.
Leukemia & Lymphoma|March 26, 2002
Second malignancies after treatment for Hodgkin's diseaseE Várady, B Deák, Z S Molnár, et al.
Orvosi Hetilap|June 29, 1997
[Merkel cell tumor]G Fónyad, A Rosta, E K Tóth, et al.
Neoplasma|May 1, 2010
Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long term follow-up resultsZ Molnar, Z Simon, Z Borbenyi, et al.
Pageof 3